BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2079 related articles for article (PubMed ID: 28823367)

  • 1. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and non-alcoholic fatty liver disease.
    Gkolfakis P; Dimitriadis G; Triantafyllou K
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):572-81. PubMed ID: 26663004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
    Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
    Hamid H; Zhang JY; Li WX; Liu C; Li ML; Zhao LH; Ji C; Ma QG
    Poult Sci; 2019 Jun; 98(6):2509-2521. PubMed ID: 30690636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
    Nistal E; Sáenz de Miera LE; Ballesteros Pomar M; Sánchez-Campos S; García-Mediavilla MV; Álvarez-Cuenllas B; Linares P; Olcoz JL; Arias-Loste MT; García-Lobo JM; Crespo J; González-Gallego J; Jorquera Plaza F
    Rev Esp Enferm Dig; 2019 Apr; 111(4):275-282. PubMed ID: 30810328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients.
    Li F; Sun G; Wang Z; Wu W; Guo H; Peng L; Wu L; Guo X; Yang Y
    Sci China Life Sci; 2018 Jul; 61(7):770-778. PubMed ID: 29948900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review.
    Mohammadi Z; Poustchi H; Motamed-Gorji N; Eghtesad S; Hekmatdoost A; Saniee P; Merat S
    Arch Iran Med; 2020 Jan; 23(1):44-52. PubMed ID: 31910634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease.
    Wang B; Jiang X; Cao M; Ge J; Bao Q; Tang L; Chen Y; Li L
    Sci Rep; 2016 Aug; 6():32002. PubMed ID: 27550547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 13. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
    Li F; Ye J; Shao C; Zhong B
    Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls.
    Deng Y; Wang H; Zhou J; Mou Y; Wang G; Xiong X
    Acta Derm Venereol; 2018 Aug; 98(8):783-790. PubMed ID: 29756631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.
    Da Silva HE; Teterina A; Comelli EM; Taibi A; Arendt BM; Fischer SE; Lou W; Allard JP
    Sci Rep; 2018 Jan; 8(1):1466. PubMed ID: 29362454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.
    Duarte SMB; Stefano JT; Miele L; Ponziani FR; Souza-Basqueira M; Okada LSRR; de Barros Costa FG; Toda K; Mazo DFC; Sabino EC; Carrilho FJ; Gasbarrini A; Oliveira CP
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):369-384. PubMed ID: 29482963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
    Wieland A; Frank DN; Harnke B; Bambha K
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1051-63. PubMed ID: 26304302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.